The artificial blood vessels market is anticipated to grow significantly in the coming years, driven by advancements in biotechnology and the rising prevalence of cardiovascular diseases. With
The artificial blood vessels market is anticipated to grow significantly in the coming years, driven by advancements in biotechnology and the rising prevalence.
Boston Scientific Co. (NYSE:BSX – Get Free Report)’s share price hit a new 52-week high on Wednesday . The company traded as high as $77.57 and last traded at $77.54, with a volume of 921333 shares traded. The stock had previously closed at $77.15. Analyst Upgrades and Downgrades Several equities analysts recently weighed in on […]
Junto Capital Management LP reduced its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 15.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,004,688 shares of the medical equipment provider’s stock after selling 528,564 shares during the period. […]
Avidity Partners Management LP cut its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 8.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,890,000 shares of the medical equipment provider’s stock after selling 175,800 shares during the quarter. […]